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Abstract
Background: Type 2 diabetes (T2D) is one of the most common chronic metabolic diseases characterized by
insulin resistance and the decrease of insulin secretion. Genetic variation can only explain part of the heritability of
T2D, so there need new methods to detect the susceptibility genes of the disease. Epigenetics could establish the
interface between the environmental factor and the T2D Pathological mechanism.
Results: Based on the network theory and by combining epigenetic characteristics with human interactome, the
weighted human DNA methylation network (WMPN) was constructed, and a T2D-related subnetwork (TMSN) was
obtained through T2D-related differentially methylated genes. It is found that TMSN had a T2D specific network
structure that non-fatal metabolic disease causing genes were often located in the topological and functional
periphery of network. Combined with chromatin modifications, the weighted chromatin modification network
(WCPN) was built, and a T2D-related chromatin modification pattern subnetwork was obtained by the TMSN gene
set. TCSN had a densely connected network community, indicating that TMSN and TCSN could represent a
collection of T2D-related epigenetic dysregulated sub-pathways. Using the cumulative hypergeometric test, 24
interplay modules of DNA methylation and chromatin modifications were identified. By the analysis of gene
expression in human T2D islet tissue, it is found that there existed genes with the variant expression level caused
by the aberrant DNA methylation and (or) chromatin modifications, which might affect and promote the
development of T2D.
Conclusions: Here we have detected the potential interplay modules of DNA methylation and chromatin
modifications for T2D. The study of T2D epigenetic networks provides a new way for understanding the
pathogenic mechanism of T2D caused by epigenetic disorders.
Background
As one of the fastest growing diseases in the world, T2D
has developed a main public health problem with more
than 280 million people affected by this disease, and is
the major type of diabetes with about 90% patients of all
the diabetes patients [1]. T2D is characterized by insulin
resistance and the decrease of insulin secretion [2], and
the major complications comprise the abnormally high
or low blood glucose caused by diabetes related medica-
tions, the heart and blood vessel disease, osteoporosis,
skin and mouth problems, and the damage of other
organs, including kidneys, eyes, feet, nerves and so on.
T2D is also the risk factor for Alzheimer’s disease and
vascular dementia. T2D could be diagnosed by detecting
the levels of blood glucose, glucose tolerance and
HbA1c (glycosylated haemoglobin) [3].
In the unbiased genome-wide studies on T2D risk
genes, the insulin-producing b cells in islets have been
considered as the crucial object of researches [4]. The
pancreatic b cells were stimulated to secrete insulin to
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regulate the homoeostasis of the blood glucose by the
postprandial high levels of blood glucose [5]. Until now,
hundreds of genetic variations related with T2D or glu-
cose/insulin have been identified by GWAS (Genome
Wide Association Studies) [6-9]. Most T2D risk genes
identified in GWAS performs the biological processes
which affect the number or function of the pancreatic
b cells, emphasizing the important effect of b cells in the
occurrence and development of T2D [10]. Currently, the
variances of molecular level in human islets have been
analyzed systematically by the integration of GWAS,
cDNA Chips and the measurement of the response reac-
tion of insulin for glucose and HbA1c [11]. In another
study, a manually created database T2DGADB was built
using the genetic association data provided by 701 publi-
cations of T2D studies, including the data source derived
from GWAS and Meta analysis [12]. But these genetic
variants could only explain part of the heritability of
T2D, so there need for the new methods to identify the
T2D susceptibility genes.
Most previous studies often investigated the T2D etiol-
ogy in the field of genetics, but the recent researches
found that the environmental and lifestyle factors could
also affect the T2D pathogenesis [13], in addition to the
genetic influence. And epigenetic variations could estab-
lish the links between the environmental exposure and
pathological mechanism of T2D [14,15]. Epigenetic varia-
tions were heritable and reversible, which were consid-
ered to play an important role in metabolic diseases.
As the major environmental risk factors of T2D,
the unhealthy diet causing obesity and sedentary lifestyle
might cause the epigenetic changes and even promote
the occurrence of T2D [16]. Current studies have shown
that DNA methylation and histone modifications could
change by the metabolic or nutritional disorders and
other environmental factors, thereby affecting the devel-
opment of the pancreatic b cell and the function of insu-
lin secretion to cause the decline of the sensitivity of
insulin response, and ultimately lead to the occurrence of
T2D. There is also evidence to suggest that the low birth
weight is considered as an indicator of fetal malnutrition
and associated with Impaired glucose tolerance (IGT)
and T2D later in life [17]. Recently, the genome-wide
maps of epigenetic markers have been described in sev-
eral cell lines of mouse and human, including the human
islet tissue. A map of histone modifications for human
islet tissue was constructed by ChIP-seqencing (ChIP-
seq), including the active (H3K4me1, H3K4me2 and
H3K4me3) and inhibitive (H3K27me3) histone modifica-
tions, which was considered as the reference to the
researches for the T2D etiology [18]. These epigenetic
findings provide a reliable resource for understanding the
crucial roles of the regulatory elements for the human
islets in T2D susceptibility.
The statistically significant overlaps between the com-
plex disease pathologies might be caused by the protein
variances which are involved in the same pathways or pro-
tein complexes, or have the same or similar functions [19].
The increasing evidences also showed that the proteins,
whose corresponding genes contributed to the same dis-
ease, often tend to interact with each other sharing the
same or similar biological processes and co-expressing in
the same tissues [20]. Therefore, the computational sys-
tems biology methods based on network theory have been
widely used to investigate into the human complex dis-
eases. In the network-based approaches, it is hypothesized
that the biological networks consist of the interacting pro-
teins with specific functions [21]. The functional interac-
tions could be shown in the interaction level, including
physical interaction, co-expression, co-regulation and phe-
notypic interaction. The functionally related genes usually
cluster in the biological networks, and the interactome
could explain the complexity of the network linkages. The
human interactome has been used to identify the potential
disease-causing genes. In a recent research, based on the
combination of human interactome and the genome-wide
DNA methylation, a weighted cancer-related DNA methy-
lation network was constructed and a list of potential can-
cer-related genes with aberrant DNA methylation was
prioritized [22]. Still, there are few studies about disease
network combined the DNA methylation and chromatin
modifications with the human interactome.
As one of the metabolic diseases affecting the health
and normal life, T2D is related with genetic, autoim-
mune, environmental and other factors. Recent studies
have shown that the epigenetic factors also contribute
to the pathogenesis of T2D, but still unclear currently.
In this study, based on the network theory, the two
major epigenetic modifications, DNA methylation and
chromatin modifications were used to construct T2D-
related DNA methylation network and chromatin modi-
fication pattern network, respectively. The interplay
modules of both DNA methylation and chromatin mod-
ifications were detected, and then the genes with epige-
netic disorders of T2D were identified. These genes and
modules might affect the development of T2D by the
epigenetic dysregulation, and could be the biological
markers for the T2D etiology.
Results
Identification of T2D-related differentially methylated
genes
Variations in DNA methylation with Pathology were
found in a variety of cancers and other complex dis-
eases, including diabetes and autoimmune diseases. The
patterns of genome-wide DNA methylation were diverse
in different states, representing the characteristics under
the certain state. Comparing the distributions of DNA
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methylation of T2D and control samples covering 14495
genes, it is shown that there was a bimodal distribution
in the control samples (Figure 1A). 8585 genes account-
ing for 59.22% of the total were hypomethylated (methy-
lation level = <0.2), and a few genes in the control
samples were hypermethylated (methylation level> =
0.8), including 930 genes (6.42%). Figure 1B revealed the
DNA methylation distribution of T2D islet tissue had
only one peak in the hypomethylation region. Although
DNA methylation distribution in T2D state was differ-
ent from the control state, the majority of genes showed
the low DNA methylation level with the number of
8677 genes accounting for 58.86% of the total, which
was similar with the count of control state. But the
number of genes with high DNA methylation levels was
significantly reduced by nearly 1/3, containing 642 genes
and only accounting for 4.43%,
Based on the significant differences of genome-wide
DNA methylation distributions between T2D and control
samples, it is suggested the differentially methyalted genes
might contribute to the occurrence and development of
T2D. 1756 differentially methylated genes were identified
using SAM with the FDR value < 0.05, most of which were
hypomethylated and only 3 genes were hypermethylated
(Figure 1C). Comparing differentially methylated genes in
T2D and control groups (Figure 1D), the mean value of
differentially methylated genes were 0.46 and 0.54 in T2D
and control group, respectively. In control group, the dif-
ferentially methylated genes were mainly in the range of
0.6 to 0.8, but mainly in the range of 0.4 to 0.6 in T2D
group. For the differentially methylated genes in control
group, there were 200 hypermethylated genes (methylation
level >= 0.8), while only 82 genes in T2D group. Reversely,
for the hypomethylated genes, there were 165 genes in
control group, much less than the 270 genes in T2D
group. The results indicated that the DNA methylation
patterns reflected the global hypomethylation in the gen-
ome of T2D islet cells and there was a set of genes with
the DNA methylation level reduced in T2D might play the
crucial role in the development of the T2D pathology.
Figure 1 Identification of T2D-related differentially methylated genes. The distributions of the genome-wide DNA methylation for control
and T2D were compared shown in (A) and (B). (C) The unsupervised hierarchical clustering heatmap of T2D and control samples, red bar
represents the T2D samples and blue bar represents the control samples. (D) Comparison of the DNA methylation levels for the T2D-related
differentially methylated genes in T2D and control groups. The red colour represents the T2D samples and the blue colour represents the
control samples.
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Construction and analysis of T2D-related DNA
methylation weighted networks
DNA methylation in complex disease has become the hot
topic of intense investigation. In this study, T2D-related
network was constructed by the DNA methylation level of
genes in genome-wide scale. We hypothesized that DNA
methylation variances related with T2D may cluster in the
complex network, targeting the specific molecular path-
ways. Based on the integrated background network and
T2D-related DNA methylation data with the genome-wide
scale (see Methods for details), the weighted methylation
PPI network (WMPN) was built, composing of 9014 inter-
actions (edges) and 4483 genes (nodes). It includes 328
differentially methylated genes (Figure 2A).Using the sub-
set of 328 differentially methylated genes as the seed set,
the T2D-related DNA methylation weighted subnetwork
(TMSN) was extracted form WMPN (see Methods for
details) (Figure 2B). TMSN contains the seed genes and
the genes which connect with the seed genes in WMPN,
comprising 1197 genes (nodes) and 6386 interactions
(edges). The largest component of TMSN was comprised
of 6139 interactions and 856 genes which contained 166
seed genes. It is generally considered that proteins often
interacts with each other if owning the similar phenotypes
in the complex diseases. Thus, TMSN might represent a
set of epigenetic-specific dysregulated pathways caused by
the aberrant DNA methylation, contributing to the epige-
netic disorders of T2D.
In the subsequent analysis, the network topological fea-
tures of WMPN and TMSN were compared (see Methods
for details). WMPN and TMSN all followed the power-
law distribution, with rWMPN=1.627 and rTMSN=1.126
(Figure 2C). They were called as scale-free networks with
the characteristics of a few Hub nodes and the majority
Figure 2 The construction and topological analysis of WMPN and TMSN. (A) There are 4483 nodes and 9014 connections in WMPN. The
nodes represent genes and connections represent interactions. The yellow nodes represent the T2D-related differentially methylated genes. (B)
TMSN contains 1197 genes and 6386 interactions, in which the yellow nodes also represent the T2D-related differentially methylated genes. (C)
The comparison of the degree distributions of WMPN and TMSN. The blue and red colours represent WMPN and WMPN, respectively. (D) The
comparison of clustering coefficient between the TMSN giant component and the local null randomization. (E) The comparison of betweenness
between the TMSN giant component and the local null randomization.
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nodes with low connectivity (Figure 2C). As shown in the
Table 1, the network topological features were calculated.
TMSN has the network average degree and clustering
coefficient much significant higher than that of WMPN,
the degrees of TMSN and WMPN were 10.67 and 6.77,
and clustering coefficients were 0.42 and 0.26, respectively.
In order to assess the reliability of TMSN, the global
network randomization was performed (see Methods for
details). The topological features of the 1000 global ran-
dom subnetworks were calculated and compared with
TMSN. The results showed that TMSN was significantly
different from the global random null model, the three
topological features were all significant less than the
global random null model with the empirical p value of
< 0.01 (Table 1). The possible reason for this phenom-
enon might be that the seed set was a collection of
genes with the relative low degree in WMPN resulting
in the TMSN gene set with low degrees. Therefore,
comparing the node and edge sizes of TMSN and global
random null model, it is found that the sizes of the
node set and the edge set for TMSN were less than the
sizes of all the 1000 global random subnetworks. And
the average degree of the seed gene set was 4 in
WMPN, less than all the average degrees of the 1000
random seed gene sets.
To validate the statistical significance of the network mod-
ularity for TMSN, the giant component of TMSN was
extracted. The local network randomization was performed
and 1000 local random subnetwork giant components were
constructed (see Methods for details). The topological
features of local random null model were calculated and
compared with the giant component of TMSN. The results
shown that the clustering coefficient and betweenness of the
TMSN giant component were 0.51 and 3860, much higher
than the local random null model, indicating the statistically
significant differences in the network structures between
TMSN and the local random null model (Figure 2D and
2E).The findings revealed that TMSN might reflect the rela-
tionship between T2D-related genes with aberrant DNA
methylation and disease cause genes.
Analysis of the T2D-related differentially methylated
genes
Some researches on disease networks had indicated that
the vast majority of disease-related genes were nonessential
and did not tend to encode the hub proteins. They often
located in the functional the topological periphery of the
complex biological networks [21]. Based on the hypothesis
above, the T2D-related seed gene set was compared with a
set of Housekeeping genes and a set of cancer genes. The
Housekeeping genes were derived from Cheng et al. [23],
including 2064 genes and 1050 genes were mapped into
WMPN. And then, 1000 random gene sets with the same
size of 1050 were obtained by sampling from the WMPN
gene set. The average degree of the Housekeeping genes
was 10.50, much higher than all the 1000 average degrees
of the random gene sets (Figure 3). Cancer gene set was
obtained from the National Cancer Institute for Cancer
Gene Index, including 6474 genes, and 539 genes were
remained after mapped into the WMPN gene set. Also
1000 random gene sets with the same size of 539 were
obtained by sampling from the WMPN gene set. The aver-
age degree of the cancer genes was 11.73, significantly
higher than all the 1000 average degrees of the correspond-
ing random gene sets. The cancer genes were more likely
to encode the hubs, and so were the Housekeeping genes
(Figure 3).
Housekeeping genes were defined as the constitutive
genes that were required for the maintenance of basic cel-
lular function, and were expressed in all cells of an organ-
ism. Thus, the functional centrality of Housekeeping genes
determined the network topological centrality of these







Degree 6.77 10.67 13.70 <0.01
Clustering
Coefficient
0.26 0.42 0.49 <0.01
Betweenness 15700 2760 3808 <0.01
Figure 3 Comparison of the average degree for T2D-related
differentially methylated, Housekeeping and cancer genes. The
three red lines represent the average degrees of T2D-related
differentially methylated, Housekeeping and the cancer genes,
respectively. The three blue boxes represent the random null
distributions of the three gene sets, respectively.
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genes, performing the crucial functions with the high
degrees. Studies have shown that cancer-related genes
tend to perform the basic cellular functions, named with
essential genes. Therefore, the cancer gene set also had
the functional and topological centrality in complex biolo-
gical networks and played the critical role in the develop-
ment of diseases. Many researches have shown that T2D
is the chronic metabolic disease with the complex patholo-
gical mechanism unclear so far. But the causing genes of
T2D might be the nonessential genes with the non-critical
functions in organisms, so the dysregulation caused by
these genes might be the non-fatal disorders. In this study,
the average degree of T2D-related differentially methylated
genes was only 4.00, significant less than all the random
gene sets, revealing that T2D-related genes had the func-
tional and topological peripherality in TMSN obtained
from WMPN was the biological significance.
The pattern of chromatin modifications for T2D
Recent studies have shown that DNA methylation, his-
tone modifications and other epigenetic modifications
often effect together and lead to the common results.
Histone modifications were considered to play the
important roles in the regulation of the gene expression
and the maintenance of chromosomal structure. In this
study, we examined five chromatin modifications, includ-
ing H3K4me1, H3K4me3, H3K79me2, CTCF (CCCTC
factor) and DnaseHS (Dnase Hypersensitive Sites) in
T2D.
The chromatin modification intensities were mapped
into the TSS proximal regions of genes in the genome-
wide scale, and the distribution patterns of chromatin
modifications were compared for all the genes and the
T2D-related differentially methylated genes (Figure 4A-
D). It was found that the intensities of chromatin modi-
fications in T2D-related differentially methylated genes
were significantly different from those in genome-wide
scale. Based on the results above, we further compared
the chromatin modifications in T2D-related differen-
tially and non-differentially methylated genes (Figure
4E). The results revealed that the chromatin modifica-
tion intensities in T2D-related differentially methylated
genes were much higher than those in non-differentially
methylated genes, indicating the specific pattern of
chromatin modifications in T2D. There were 1756 T2D-
related differentially methylated genes in all, including
270 hypomethylated genes and only 82 hypermethylated
genes with the count 15.38% and 4.67% of the total
number, respectively. There were 12337 non-differen-
tially methylated genes, including 127 hypomethylated
genes and 515 hypermethylated genes, accounting for
1.03% and 4.17% of the total, respectively. For the differ-
entially and non-differentially methylated gene sets, the
count ratios of the hypermethylated genes were
approximate, while the count ratio of the hypomethy-
lated genes in differentially methylated gene set was
much more than that in non-differentially methylated
gene set (fold change above 15).
The T2D-specific chromatin modification patterns
might result in the aberrance of DNA methylation, which
affected the expression levels of the corresponding genes
or directly affected the interactions of DNA histone to reg-
ulate the expression levels of the genes. Therefore, as same
as DNA methylation, chromatin modifications also had
the important roles in the occurrence and development of
T2D. DNA methylation and chromatin modifications were
combined to investigate the interplay for the epigenetic
dysregulation contributing on the development of T2D in
the subsequent analysis.
Construction and analysis of T2D-related chromatin
modification weighted networks
Here, the weighted chromatin modification PPI network
(WCPN) was constructed using the integrated back-
ground network and T2D-related chromatin modifica-
tion data, which was composed of 99528 interactions
(edges) and 9014 genes (nodes) (see Methods for details)
(Figure 5A). WCPN might represent the T2D-specific
relationship of patterns of chromatin modifications
between genes.
The findings above revealed that TMSN had the T2D-
specific network structure, which might contain a set of
epigenetic-specific dysregulated pathways caused by
the aberrant DNA methylation, contributing to the epige-
netic disorders of T2D. Furthermore, the chromatin
modification patterns of T2D-related differentially
methylated genes were significant distinguished from
those of non-differentially methylated genes, indicating
that the tight correlation between DNA methylation and
chromatin modifications in T2D. The combination of
DNA methylation and histone modifications is helpful to
the understanding of the epigenetic dysregulation of
T2D. Therefore, the chromatin modification patterns of
the T2D-related differentially methylated genes and their
connected genes were investigated. The T2D-related
chromatin modification weighted subnetwork (TCSN)
was built, composing of 16624 interactions (edges) and
863 genes (nodes), of which 156 seed genes were con-
tained (see Methods for details) (Figure 5B). The giant
component of TCSN comprises 16304 interactions and
709 genes, of which 121 seed genes inside. TCSN might
reflect the chromatin modification patterns for differen-
tially methylated genes and their connected genes in
T2D. It provides the theoretical basis for T2D-spicific
epigenetic disorders caused by the DNA methylation
aberrance and the histone modifications, and promotes
the further understanding of the epigenetic mechanisms
contributing to the occurrence and development of T2D.
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Next, the network topological features of WCPN and
TCSN were compared. And they all approximately fol-
lowed the power-law distribution, with rWCPN=1.381
and rTCSN=0.867, also called as scale-free networks
(Figure 5C). The network topological features were cal-
culated. As shown in the Table 2, the network average
degree and clustering coefficient of TCSN were much
significant higher than that of WCPN; the degrees of
TCSN and WCPN were 38.52 and 22.08; and clustering
coefficients were 0.57 and 0.13, respectively (Table 2).
But the betweenness of TCSN was 1840, higher than
that of WCPN with the betweenness value of 1330,
similar with the topological features of TMSN (Table 2).
In order to assess the reliability of TCSN, the global
network randomization was performed and 1000 global
random subnetworks were constructed (see Methods for
details). The topological features of the global random
subnetworks were calculated and compared with TCSN.
The results showed that TCSN was significantly different
from the global random null model, and two topological
features (degree and clustering coefficient) were all signif-
icant higher than the global random null model with the
empirical p value of < 0.01, while the betweenness of
TCSN is less than that of WCPN with the statistic signifi-
cance. Comparing the sizes of TCSN and the global ran-
dom null model, it is found that the sizes of the node set
and edge set for TCSN were 863 and 16624, larger than
those of all the 1000 global random subnetworks. The
results showed that the chromatin modification patterns
of T2D-related differentially methylated genes and the
associated genes tended to be similar with each other.
To validate the statistical significance of the network
modularity observed in TCSN, the giant component of
TCSN was extracted. The local network randomization
was performed to contribute 1000 local random subnet-
work giant components (see Methods for details). The
topological features of local random null model were cal-
culated and compared with the giant component of
TCSN. The results were found that the clustering coeffi-
cient and betweenness of the TCSN giant component
were 0.60 and 3860, respectively (Figure 5D and 5E),
significantly higher than the local random null model,
indicating the statistically significant differences in the net-
work structures. It is revealed that TCSN may reflect the
similar relations of chromatin modification patterns
between T2D-related aberrant DNA methylated genes and
the connected genes.
Detection of interplay modules of DNA methylation and
chromatin modifications for T2D
TMSN contained 134 components, in which the giant
component was composed of 863 genes and 6139 inter-
actions, accounting for 72.10% and 96.13% of the total,
respectively. For the giant component of TMSN, 42 DNA
methylation specific modules were detected by removing
the modules only containing 2 elements (see Methods for
Figure 4 Comparison of the chromatin modification patterns of T2D. (A) and (B) show the chromatin modification intensities of the T2D
islets in the genome-wide scale. (C) and (D) show the chromatin modification intensities of the T2D-related differentially methylated genes.
(E) The comparison the chromatin modification patterns between T2D-related differentially methylated genes and non-differentially methylated
genes. The blue boxes represent the non-differentially methylated genes and the red boxes represent the differentially methylated genes.
Liu et al. BMC Systems Biology 2014, 8(Suppl 1):S5
http://www.biomedcentral.com/1752-0509/8/S1/S5
Page 7 of 16
details). TCSN contained 29 components, and the giant
component was composed of 709 genes and 16304 inter-
actions, almost containing all of the genes and interac-
tions in TCSN with the proportions of 82.16% and
98.08%, respectively. It was indicated that the chromatin
modification patterns of T2D-related differentially
methylated genes and their connecting genes were high
similar. Finally, after removing the modules under the
threshold, 21 chromatin modification specific modules of
T2D were detected from the giant component of TCSN
(see Methods for details). The dysregulation of biological
processes in organisms were often resulted by the com-
bined effects of DNA methylation and chromatin modifi-
cations. The results above showed that the chromatin
modification intensities of T2D-related differentially
methylated genes were significant higher than those of
non-differentially methylated genes, indicating the T2D-
specific chromatin modification patterns.
Thus, as the important epigenetic modifications, DNA
methylation and chromatin modifications contributed to
the epigenetic disorders of T2D together. In the 42
T2D-related DNA methylation modules and 21 T2D-
related chromatin modification modules, the interplay
Figure 5 The construction and topological analysis of WCPN and TCSN. (A) There are 9014nodes and 99528connections in WCPN. The
nodes represent genes and connections represent interactions. The yellow nodes represent the T2D-related differentially methylated genes.
(B) TCSN contains 863 genes and 16624 interactions, in which the yellow nodes also represent the T2D-related differentially methylated genes.
(C) The comparison of the degree distributions of WCPN and TCSN. The blue and red colours represent WCPN and WCPN, respectively. (D) The
comparison of clustering coefficient between the TCSN giant component and the local null randomization. (E) The comparison of betweenness
between the TCSN giant component and the local null randomization.







Degree 22.08 38.53 4.97 <0.01
Clustering
Coefficient
0.13 0.57 0.31 <0.01
Betweenness 1840 1330 271 <0.01
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modules of DNA methylation and chromatin modifica-
tions for T2D were detected by the cumulative hyper-
geometric test method (see Methods for details). Of the
two groups of modules, there were 90 overlaps, and
the minimal overlap only contained one gene, while the
maximum overlap contained 44 genes. The module
combinations (sub-modules) with the smallest overlap
size of 3 were remained, and after the bonferroni multi-
ple testing correction (Bonferroni corrected p value <
0.05), 24 significantly enriched sub-modules were identi-
fied and considered as the interplay modules of DNA
methylation and chromatin modifications (see Addi-
tional file 1).
Due to the absence of a gold standard to evaluate
whether the identified interplay modules were related to
T2D, we used the public database PubMed as the refer-
ence list [22,24]. For the 24 interplay modules, there were
205 genes in all. The automated texting of literature for
the relationship of the interplay module genes and T2D
was by the query terms that contained these genes and
type 2 diabetes /insulin for the co-occurrence either in an
abstract or in the title of previous publications. The results
showed that 52 genes were related to T2D or insulin with
745 publications (see Additional file 2). And these genes
were involved in the almost interplay modules, of which
only 4 interplay modules had no publication support for
their member genes (see Additional file 3). There may
exist the false positive relations for the text-mining of
PubMed, because the co-occurrence of the two terms
donot mean the gene is indeed related with T2D or insu-
lin. And also, the two terms may be the negative relations
for the co-occurrence. Because of the positive and negative
relations both existing in the titles and abstracts, the devia-
tion could be ignore. So, the results could reflect the rela-
tionship between the genes and T2D.
These interplay modules might contribute to the epige-
netic disorders of T2D through the combined effects of
DNA methylation and chromatin modifications. Also,
T2D-spicific chromatin modification patterns might lead
to the aberrance of DNA methylation levels and further
affect to the expression levels of the corresponding genes,
or directly affect the binding of DNA and histone to regu-
late the expression levels of genes. On the other hand, the
aberrant DNA methylation could directly affect the
expression without the cooperation of chromatin modifi-
cations. In the following analysis, the effects of DNA
methylation and chromatin modifications on gene expres-
sion were investigated.
The analysis of the effects of DNA methylation and
chromatin modifications to the expression of genes
Firstly, we investigated into the relationship between
DNA methylation and expression for the corresponding
genes. A set of expression data for T2D and control
states was derived from Jalal Taneera et al..82 upregu-
lated genes and 447 downregulated genes were identi-
fied. Then, the differentially expressed genes were
mapped into the differentially methylated genes, and a
subset of 36 genes which both differentially expressed
and methylated was extracted. In TMSN gene set, there
were 11 differentially expressed genes were included
(Entrez gene ID: 1969, 2778, 5037, 5121, 6367, 7163,
10518, 22924, 28964, 84790, and 164284). Many current
researches suggested that DNA methylation was nega-
tively correlated with gene expression and even affected
the expression levels of corresponding genes. In this
study, the Spearman correlation between DNA methyla-
tion and the expression of the corresponding gene was
calculated, and the correlation coefficient was -0.3969
(p value < 2.2E-16), consistent with the previous studies.
The linear regression model of DNA methylation and
gene expression was built, and the 95% prediction inter-
val was remained. It is considered that the genes expres-
sion levels within this threshold were affected by
the genes DNA methylation levels (y =-2.793x +7.561)
(Figure 6). 10923 genes had both the DNA methylation
and expression levels, of which 10323 genes were above
the threshold of the 95% prediction interval, indicating
that the expression levels of these genes might be regu-
lated by the DNA methylation of the corresponding
gene.
In the next analysis, the interplay modules of DNA
methylation and chromatin modifications for the expres-
sion levels of the corresponding genes were investigated.
Module 35 in TMSN contains three genes including two
hypomethylated genes, and Module 1 in TCSN contains
seven hypomethylated genes within all 144 genes. The
overlap of the two modules contained 3 genes, and was
identified as the interplay module in which the genes
were significantly enriched with the cumulative hyper-
geometric test p value less than 0.001 (see Methods for
details) (Figure 7A). TUBA1C (tubulin, alpha 1c), is an
encoding gene of Tubulin family, which is the major
component of microtubules. It is as a skeleton to deter-
mine the Cell morphology, and with the moter proteins
together, provide a scaffold to organelles and vesicles for
the movement (see Additional file 4). This gene was both
differentially methylated and expressed in the compari-
son of the T2D and control samples. And in the analysis
of correlation between DNA methylation and expression,
the expression level of TUBA1C might be affected by the
DNA methylation level. Although, so far there has been
no reports about the relationship between the gene
TUBA1C and insulin secretion, a study on the insulin
secretion in mouse showed that a microtubule associated
protein, syntabulin, which was the necessary protein for
the glucose stress and insulin secretion protected by
cAMP. Therefore, it is considered that the microtubule
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Figure 6 The linear regression model for DNA methylation to the expression of the corresponding genes. The × axis is the DNA
methylation level for the T2D samples and the y axis is the expression level of the corresponding gene for the T2D samples. The range
between the two red lines at the bottom and top sides represent the 95% prediction interval, considering the expression levels of the genes
within this region might be affected by the DNA methylation of the corresponding genes. The middle red line represents the best-fitting line for
the DNA methylation to the expression levels in T2D.
Figure 7 Two examples of the interplay modules of DNA methylation and chromatin modifications. (A) and (B) show the two examples
of the cross-talk modules of DNA methylation and chromatin modifications in T2D. The blue and purple nodes represent the TMSN and TCSN
genes, respectively. The yellow nodes represent the T2D-related differentially methylated genes, and the light red nodes represent the
overlapping genes of the two module groups. The red and green lines represent the positive and negative correlations of the DNA methylation
patterns between the two genes, respectively. And the grey dashed lines represent the significant chromatin modification patterns between the
two linked genes.
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encoding protein of human islet tissue TUBA1C might be
related with the insulin secretion [25]. Another gene
GAPDH, connected with a differentially methyalted gene,
although the DNA methylation level of this gene was not
aberrant, researches have shown that, this gene could
change the etinal Müller cells fate in diabetes [26], and
Müiler cells are the most important retinal glial cells of
vertebrate [27]. It is shown that H3K4me3 was negatively
correlated with DNA methylation. The chromatin modi-
fication pattern of GAPDH was significantly correlated
with that of the two connected differentially methylated
genes, but the modification intensities of DNaseHS and
H3K4me3 were higher than the two differentially methy-
lated genes. The DNA methylation levels of GAPDH in
T2D and control samples were both low, and were 0.072
and 0.052, respectively, which might be associated with
the high intensities of DNaseHS and H3K4me3.
Next, another interplay module was investigated. Mod-
ule 12 in TMSN giant component contains six genes, of
which there was one differentially methylated gene with
no variance of the expression level. Module22 in TCSN
giant component contains five genes, and the differen-
tially methylated gene within the Module12 of TMSN
was included. The overlap of the two modules was four
genes with the statistical significance of the p value less
than 0.001, considered as the interplay module of DNA
methylation and chromatin modifications (Figure 7B, see
Additional file 5). CHMP1A is the differentially methy-
lated gene in the interplay module of DNA methylation
and chromatin modifications, and the DNA methylation
pattern of this gene was all negatively correlated with
that of the connected genes. The findings revealed the
specific DNA methylation pattern different from other
genes, indicating that the aberrant DNA methylation pat-
tern of CHMP1A might result in the disorders of epige-
netic modules in T2D. And the gene, ATP6V1B2,
connecting with CHMP1A, was reported a potential fac-
tor contributing to the development of T2D [28]. Next,
another connected gene ATP6V1H which was not
included in the interplay module, showed a decreasing
trend of expression level in T2D, considering that the
variance of expression level might be resulted by the
aberrant chromatin modifications. In summary, in this
study, a set of interplay modules of DNA methylation
and chromatin modifications was detected, and might
play the extremely important roles in the development
of T2D.
Discussion
In this study, based on the network theory, the T2D-
related DNA methylation and chromatin modification
networks were constructed by the integrated epigenetic
data and protein interactome, and the two networks
showed the specific topological features. The T2D-related
DNA methylation and chromatin modification modules
were detected and the interplay modules of the two epi-
genetic modifications with the statistical significance
were identified as the epigenetic markers for T2D. The
interplay modules might lead to the epigenetic disorders
by the aberrance of DNA methylation and chromatin
modifications, and affect the development of T2D. It is
helpful for the understanding of the etiological mechan-
ism caused by epigenetic disorders and the treatment
for T2D.
Here, the DNA methylation data was examined by
Human Methylation 27K BeadChip using Bisulfite con-
version technology. The genome-wide DNA methylation
chips with Bisulfite conversion technology could provide
the accurately quantified at single-base resolution level,
More than 27000 CpG sites could be interrogated by
Human Methylation 27K BeadChip, but only 14495
genes with the promoter-specific regions were covered.
And in this study, the chromatin modifications could be
mapped into the TSS proximal regions of 23679 human
Entrez genes, of which only 14356 genes had both the
DNA methylation and chromatin modifications data,
approximately 9000 genes lacked the DNA methylation
data. But the T2D-related DNA methylation data of
human islet tissue we obtained from GEO were only
detected by Human Methylation 27K BeadChip, and the
coverage of DNA methylation is the limitation for this
study.
We extracted the T2D-related differentially methylated
subnetwork from WMPN, which representing the physical
and pathway interactions between the T2D-related differ-
entially methylated genes and the connected genes. This
subnetwork showed the T2D specific DNA methylation
patterns between genes. In the analysis of the network
topological features, it is found that the topological fea-
tures of TMSN were all less than the global random null
model with the statistic significance. One reason for this
phenomenon is speculated that the most T2D-related dif-
ferentially methylated genes had the low degrees, and
leaded to the size of the TMSN extracted by these genes
less than the permutations. Considering that T2D is the
non-fatal chronic metabolic disorder, TMSN might show
this biological significance. The genes contributing to the
occurrence and development of T2D might be a set of the
nonessential genes involved in the biological processes, so
the dysregulation of these genes leaded to the non-fatal
disorder, T2D. Similarly, the non-essentiality of these
genes with the biological functions determined the periph-
erality of function and topology in the biological network.
To validate this hypothesis, Housekeeping genes and can-
cer genes were used to compare with the T2D-related dif-
ferentially methylated genes. The average degrees of the
three gene sets in WMPN were calculated, the results
showed that the average degrees of Housekeeping genes
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and cancer genes were significantly higher than that of the
WMPN gene set and the corresponding random gene sets,
while the average degree of T2D-related differentially
methylated genes was less than that of the WMPN gene
set and the corresponding random gene set. Therefore,
TMSN constructed by the T2D-related differentially
methylated genes showed the T2D specific network
characteristics.
The current studies showed that the biological events
often caused by the combination of DNA methylation
and chromatin modifications. Therefore, the epigenetic
disorders of T2D were caused by both DNA methylation
and chromatin modifications. In this study, 24 interplay
modules of DNA methylation and chromatin modifica-
tions were identified by the cumulative hypergeometric
test with the statistic significance (Bomferroni corrected
p value < 0.05), considered as the epigenetic disordered
modules of T2D by the interplay between DNA methyla-
tion and chromatin modifications. In the analysis with
the combination of the T2D expression level for human
islet tissue, it is found that there existing the aberrant
expressed genes caused by the abnormal DNA methyla-
tion and chromatin modifications. It is shown that DNA
methylation was inversely corrected with the expression
of the corresponding gene in the linear regression model.
But the Spearman correlation coefficient was only
-0.3969, seemed weakly. Only part of the genes has
shown the negative correlations between DNA methyla-
tion and expression of the corresponding gene. This phe-
nomenon could be partly explained by the reason that
the probes could not cover all the promoters in the gen-
ome-wide scale in Human Methylation 27K BeadChip
[29]. Each promoter could cover 1.9 CpG sites, but the
gene might have several promoters. While the probes in
expression chips usually could be positioned in the com-
mon exons of the all transcripts for the corresponding
gene. Therefore, the promoters that located by CpG sites
were not must be the corresponding promoter of the
transcript. So only a part of genes showed the negatively
correlations between DNA methylation and expression of
the corresponding gene. It is inconvenient for the analy-
sis of the correction of DNA methylation and expression.
Conclusions
T2D is one of the most common chronic metabolic dis-
eases, and related with genetic, autoimmune and envir-
onmental factors. Epigenetics could establish the
interface between environmental factor and the T2D
Pathology mechanism. In this study, it is considered that
the biological events were affected by both DNA methy-
lation and chromatin modifications through TMSN and
WCPN. The analysis of expression levels of human islet
tissue for T2D showed that the variances of expression
levels of the genes were caused by the aberrant DNA
methylation and the intensities of chromatin modifica-
tions. Thus, T2D epigenetic networks provide a new
way for understanding the pathogenic mechanism of
T2D caused by epigenetic disorders.
Methods
Datasets
Protein-protein interaction and pathway data. The
protein-protein interaction data were obtained from six
protein-protein interaction databases, including MINT
[30], IntAct [31], DIP [32], BioGRID [33], HPRD [34] and
BIND [35]. These data were composed of physical and
genetic interactions, which were supported by experi-
mental evidence or scientific literature. The pathway data
were derived from HumanCyc [36], Reactome [37] and
NCI nature Pathway Interaction database [38], three
manually curated pathway databases. The format of Pro-
tein-protein interaction data were usually two types, tab-
delimited ASCII format and PSI MI XML (Proteomics
Standards Initiative Molecular Interaction markup lan-
guage) format [39]. For the former format, simple binary
protein interactions could directly be extracted. For the
second format, there need to convert it to a tab-delimited
format and then obtain the simple binary protein interac-
tions. Pathway data usually was stored by BioPAX format
which representing a serial set of biochemical processes
[40]. For this format of pathway data, the biochemical
reactions were converted into binary interaction Simple
Interaction Format (SIF). Integrating these PPI and path-
way data, the redundant interactions were removed, and
the self-directed interactions were got rid of the network.
Finally, the background network consists of 15,876 genes
and 437,408 interactions.
T2D DNA methylation data. T2D related DNA methy-
lation data were derived from Michael Volkmar et al.
(GEO, accession number: GSE21232) [29], which con-
tained 11 normal samples and 5 T2D samples of T2D in
human islet tissue. DNA methylation level of these islet
tissue samples were detected by Illumia HumanMethyla-
tion27 BeadChip. In this assay, genome-wide scale genes
were detected at single-nucleotide resolution, covering
14495 genes. 27578 probes were contained in Human-
Methylation27 assays, in which many genes may contained
two or more probes. The average DNA methylation values
of the genes with multiple probes were calculated as the
DNA methylation level of the corresponding gene. Finally,
the DNA methylation levels of 14495 genes with Entrez
gene IDs for 16 human islet tissue samples were obtained
for the subsequent analysis.
T2D expression data. T2D-related expression data
were derived from Jalal Taneera et al. (GEO, accession
number: GSE38642) contained 63 islet tissue samples,
including nine T2D samples and 54 normal samples [11].
The expression levels of the islet tissues were interrogated
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by Affymetrix GeneChip Human Gene 1.0 ST whole tran-
script array containing the well annotated genes based on
RefSeq and Ensembl database. For the expression data for
human islet tissue, 18808 probes were contained in this
array, in which many genes were corresponding with sev-
eral probes. Similar to the DNA methylation data, for the
genes with the multiple probes, the average expression
value represents the expression level of the corresponding
gene. Finally, the expression levels of 14534 genes with
Entrez gene IDs for 63 human islet tissue samples were
obtained for the subsequent analysis.
T2D chromatin modifications data. Chromatin modifi-
cations were composed of H3 lysine methylation modifica-
tions (K4me1, K4me2, K79me2), DNaseI Hypersensitive
sites and CCCTC factor (CTCF) data for human islet tissue
of T2D patients, which derived from Michael L. Stizel et al.
(GEO, accession number: GSE23784) [41]. The histone
modifications and CTCF were sequenced by ChIP-seq
using the Illumina GAll, and the DNaseI Hypersensitive
sites were also sequenced by DNase-seq using the Illumina
GAll platform. The intensity of chromatin modifications
for TSS proximal regions of the genes on a genome-wide
scale were calculated using the peaks identified by MACS.
If the middle site of the peak was located in the range of
TSS proximal region, the value was accumulated for the
TSS proximal region of the corresponding gene. Finally,
the chromatin modification intensities were matched into
23680 genes with the TSS proximal regions.
TSS proximal region data. The TSS proximal regions
of genes were defined as the region of +-2Kb up-/down-
stream from the TSS (-2000bp/+2000bp around Tran-
scription Start Site). The TSS information of human
genome was downloaded from UCSC with the version of
NCBI 36/hg18 (http://genome.ucsc.edu/cgi-bin/hgTa-
bles?command=start).
Identification of differentially expressed genes and
differentially methylated genes
Based on adjusted t tests, Significance Analysis of Micro-
arrays (SAM) method could identify the gene set with
statistically significance changes in two states (e.g. disease
vs. control) [42]. For the expression data of human islet
tissue, A FDR adjusted P value of <0.05 was used to iden-
tify differentially expressed genes between T2D and con-
trol samples by SAM method. For the DNA methylation
data of human islet tissue, using the same criterion, the
T2D and control samples were compared and the differ-
entially methylated genes with the FDR value lower than
0.05 were identified by SAM. For the genes with the mul-
tiple probes, the average expression/DNA methylation
value represents the expression/DNA methylation level
of the corresponding gene. SAM method was implemen-
ted in the samr package (R version 2.15.2, Bioconductor
version 2.3).
Construction of WMPN, weighted methylation PPI
network and TMSN, T2D-related DNA methylation
subnetwork
Construction of weighted methylation PPI network
(WMPN). Based on the integrated protein-protein and
functional interaction data source, the DNA methylation
values of the any gene pair interacted with each other
were calculated by the similarity measure of Pearson cor-
relation. The gene pairs showing Pearson correlation > 0.8
or < -0.8 with the P value of < 0.05 were considered as the
significant interactions, and those with no statistical signif-
icance were pruned from the network. After the edges
filtering, the weighted methylation PPI network (WMPN)
was constructed. Pearson correlation coefficient was
implemented in R (http://www.r-project.org).
Construction of T2D-related DNA methylation
subnetwork(TMSN). As the seed genes, the differentially
methylated genes were mapped into WMPN. And then,
the seed genes and the genes which were the first neigh-
bours with the seed genes were obtained as the node set,
the interactions between these genes were obtained as
the edge set. Finally, T2D-related DNA methylation sub-
network (TMSN) was composed of the node set and the
edge set.
Construction of WCPN, weighted chromatin modification
PPI network and TCSN, T2D-related chromatin
modification subnetwork
Construction of weighted chromatin modification
PPI network (WCPN). Similarly with the construction
of WMPN, The chromatin modificaition values of the
any gene pair connected with each other were calculated
by Pearson correlation coefficient, including H3K4me1,
H3K4me3, H3K79me2, DNase Hypersensitive Sites and
CTCF. The gene pairs showing the Pearson correlation
> 0.8 or < -0.8 with the P value of < 0.05 were remained
and considered as the significant interactions. Thus, the
weighted chromatin modification PPI network (WCPN)
was constructed. Pearson correlation coefficient was
implemented in R (http://www.r-project.org).
Construction of T2D-related chromatin modifica-
tion subnetwork (TCSN). The chromatin modification
patterns of the T2D-related genes with aberrant NDA
methylation were analyzed. The collection of TMSN
gene set was mapped into WCPN and the connections
of chromatin modification patterns between these genes
were extracted from WCPN as the edge set. The TMSN
gene set and their chromatin modification pattern con-
nection set composed the T2D-related chromatin modi-
fication subnetwork (TCSN).
The analysis of network topological features
Network biology provides a quantitative description of
the characteristics of biological systems network. In this
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study, we examined the topological features of networks,
including degree (connectivity), degree distribution, clus-
tering coefficient and Betweenness [43]. The topological
features of networks were implemented in the RBGL
package (R version 2.15.2, Bioconductor version 2.3) and
a cytoscape plugin NetworkAnalyzer (Version 2.8,
Cytoscape 2.8) [44]. And the network visualization was
performed using Cytoscape (http://www.cytoscape.org/).
Detection of network modules
Using the Cytoscape plugin MCODE, the T2D-related
DNA methylation and chromatin modification patterns of
modules were detected from the giant components of
TMSN and TCSN, respectively. The algorithm of MCODE
could detect the regions where the nodes closely connected
with each other in the large-scale biological network. And
based on the density of the neighbour nodes of a node, the
method weighted a node and extended the connectivity to
identify the dense regions [45].
Identification of interplay modules between chromatin
modification and DNA methylation
The sub-modules of the DNA methylation modules and
chromatin modification modules were considered as the
candidate interplay modules. Using cumulative hypergeo-
metric test, the statistically significant interplay modules of
DNA methylation and chromatin modifications for T2D
were detected with the formula as followed:














N represents the total number of the genes of TMSN
and TCSN. M and H are defined as the genes counts of
the DNA methylation modules and chromatin modifica-
tion modules, respectively. K is the number of the over-
lapped genes of the two modules (the gene numbers of the
sub-modules). The cumulative hypergeometric probability
of this formula refers to the probability that hypergeo-
metric random variable × is greater than or equal to the
specified lower limit K. The p value could be calculated to
evaluate the enrichment significance of the sub-modules
for the two module groups. So, the sub-modules with the
Bonferroni corrected p value < 0.05 were identified as the
interplay modules of DNA methylation and chromatin
modifications for T2D.
Network randomization
Global network permutation. In order to assess the
global connectivity of TMSN in the overall network, the
random seed gene sets with the equal size of the seed
gene set were collected from WMPN, repeating 1000
times. Finally, 1000 random subnetworks were con-
structed by the random seed genes and their connected
genes in WMPN. For the reliability of TCSN, the con-
struction of the 1000 global random subnetworks was
similar with that of TCSN by sampling the random gene
sets with the equal size of TMSN node set from WCPN.
By calculating the network topological features including
degree, clustering coefficient and betweenness, the
observed subnetwork and the 1000 random networks
were compared, and the empirical p value was used to
measure the differences with the statistical significance
between the observed subnetwork and the global null
hypothesis.
Local network permutation. To evaluate the statisti-
cal significance of the modularity for TMSN and TCSN,
a local rewiring algorithm was performed that main-
tained the same size of nodes and edges of the network
but the connections was rewired. The degree-preserving
random rewiring algorithm was implemented as follows
[46]:
Randomly selected two degrees E (a - b) and E (c - d),
and a, b, c, d ∈ G(V), G(V) and G(E) are represented as
the node set and the edge set, respectively. If E’(a-d) and
E’(b-c) /∈ G(E), removed the two edges E’(a-d) and E’(b-c),
and then, added the new edges E’(a-d) and E’(b-c), viz.
E(a - b, c - d)® E’(a - c, b - d); otherwise, there is nothing
changed of the network in this step. That 50% attacks and
rearrangements were performed to create the local ran-
dom subnetwork, repeating 1000 times. For each random
subnetwork, the network topological features were calcu-
lated and compared with the observed subnetwork. Finally,
using the empirical p value, the deviations of the observed
subnetwork from the local null hypothesis were measured.
Additional material
Additional file 1: The list of interplay modules of DNA methylation
and chromatin modifications. This file describes the interplay modules
of DNA methylation and chromatin modifications in T2D with the
statistic significance identified by the cumulative hypergeometric test.
The first column is the modules ID in TCSN, and the second column is
the gene number of the corresponding module in TCSN. The third
column is the module ID in TMSN and the corresponding number of
genes is shown in the forth column. The fifth column represent the
overlap the DNA methylation module and the chromatin modification
module. And the last column is the Bonferroni p values for the
cumulative hypergeometric test.
Additional file 2: The PubMed validation for the interplay module
genes. This file lists the PubMed literature for the relationship of the
genes included in the interplay modules and the T2D or insulin. The first
and the second columns are the Entrez IDs and the official symbols for
the interplay module genes, respectively. And the last column is the
PubMed IDs for the literature that validated the relation of the genes
and T2D.
Additional file 3: The PubMed validation for the interplay modules.
This file shows the PubMed validation for interplay modules. The first
and the second columns represent the interplay module IDs and their
member counts. The next two columns show the gene lists which were
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supported by the literature and their counts in each interplay module.
And the last column shows the literature counts for the interplay
modules.
Additional file 4: The GO function enrichment for the interplay
module from TMSN module35 and TCSN module1. This file shows
the GO function enrichment results for the DNA methylation and
chromatin modification interplay module in Figure 7B with the p value
less than 0.05. The first column is the enriched GO ID, the middle
column is the name of the enriched GO term, and the last column is the
corresponding p value.
Additional file 5: The GO function enrichment for the interplay
module from TMSN module22 and TCSN module12. This file shows
the GO function enrichment results for the DNA methylation and
chromatin modification interplay module in Figure 7A with the p value
less than 0.05. The first column is the enriched GO ID, the middle
column is the name of the enriched GO term, and the last column is the
corresponding p value.
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